Application no. and date | 11746252.3 (espacenet) (Federated) (European Patent Register), 20110822 | Patent/reg. no. and date | DK/EP 2606070, 20161221 | Publication date | 20130626 | Priority no. and date | US 375408 P, 20100820 | EP pub. no. and date |
EP 2606070 20130626 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 4056 Basel, CH | Applicant ref. no. | SH/GP/154814 | Inventor | KUNZ, Christian Carsten Silvester, Morphosys AG Lena-Christ-Strasse 48
82152 Planegg, DE, ELIS, Winfried, MORPHOSYS AG Lena-Christ-Strasse 48
82152 Planegg, DE, ETTENBERG, Seth, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge
Massachusetts 02139, US, GARNER, Andrew Paul, Novartis Institutes for BioMedical Research Inc. 250 Massachussetts Avenue Cambridge
Massachusetts 02139, US, HAUBST, Nicole, MORPHOSYS AG Lena-Christ-Strasse 48
82152 Planegg, DE, REISINGER SPRAGUE, Elizabeth Anne, Novartis Institutes for BioMedical Research Inc. 250 Massachussetts Avenue Cambridge
Massachusetts 02139, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/32 (2006.01) | Title | Antistoffer for den epidermiske vækstfaktorreceptor 3 (HER3) | Int. application no. | EP2011064407 | Int. publication no. | WO2012022814 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|